ARIEL CAPITAL MANAGEMENT LLC 13D and 13G filings for Core Laboratories N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 09:10 am Purchase |
2022-12-31 | 13G | Core Laboratories N.V. CLB |
ARIEL CAPITAL MANAGEMENT LLC | 9,703,122 20.900% |
1,898,815 (+24.33%) |
Filing |
| 2022-02-14 08:41 am Purchase |
2021-12-31 | 13G | Core Laboratories N.V. CLB |
ARIEL CAPITAL MANAGEMENT LLC | 7,804,307 16.900% |
634,890 (+8.86%) |
Filing |
| 2021-12-10 1:49 pm Purchase |
2021-11-30 | 13G | Core Laboratories N.V. CLB |
ARIEL CAPITAL MANAGEMENT LLC | 7,169,417 15.500% |
2,648,416 (+58.58%) |
Filing |
| 2021-02-12 09:52 am Sale |
2020-12-31 | 13G | Core Laboratories N.V. CLB |
ARIEL CAPITAL MANAGEMENT LLC | 4,521,001 10.200% |
-52,700 (-1.15%) |
Filing |
| 2020-12-09 4:05 pm Purchase |
2020-11-30 | 13G | Core Laboratories N.V. CLB |
ARIEL CAPITAL MANAGEMENT LLC | 4,573,701 10.300% |
4,573,701 (New Position) |
Filing |